Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes

Journal of Clinical Microbiology

Volumn 54, Issue 10, 2016, Pages 2470-2484

  Thomson, Emma ^a   Ip, Camilla L C ^b   Badhan, Anjna ^d   Christiansen, Mette T ^e   Adamson, Walt ^a   Ansari, M Azim ^c   Bibby, David ^d   Breuer, Judith ^e   Brown, Anthony ^c   Bowden, Rory ^b   Bryant, Josie ^e   Bonsall, David ^c   Da Silva Filipe, Ana ^a   Hinds, Chris ^a   Hudson, Emma ^c   Klenerman, Paul ^c   Lythgow, Kieren ^d   Mbisa, Jean L ^d   McLauchlan, John ^a   Myers, Richard ^d   Piazza, Paolo ^b   Roy, Sunando ^e   Trebes, Amy ^b   Sreenu, Vattipally B ^a   Witteveldt, Jeroen ^f   Barnes, Eleanor ^c   Simmonds, Peter ^c,f   more..

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC VARIATION; GENOTYPING TECHNIQUE; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; METAGENOMICS; MIXED INFECTION; NEXT GENERATION SEQUENCING; NONHUMAN; PEGIVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES DIVERSITY; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; ANTIVIRAL RESISTANCE; CLASSIFICATION; CLINICAL TRIAL; DNA SEQUENCE; EVALUATION STUDY; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIGH THROUGHPUT SEQUENCING; MULTICENTER STUDY; PROCEDURES; UNITED KINGDOM; VIROLOGY;

DRUG RESISTANCE, VIRAL; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; SEQUENCE ANALYSIS, DNA; UNITED KINGDOM;

EID: 84991280301     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00330-16     Document Type: Article

References (17)

1. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. 2015. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61:77-87. http://dx.doi.org/10.1002/hep.27259.
2. Jacobson IM, Dore GJ, Foster GR, Fried MW, Radu M, Rafalsky VV, Moroz L, Craxi A, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Scott J, Sinha R, Beumont-Mauviel M. 2014. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 384:403-413. http://dx.doi.org/10.1016/S0140-6736(14)60494-3.
3. Kowdley KV, Lawitz E, Crespo I, Hassanein T, Davis MN, DeMicco M, Bernstein DE, Afdhal N, Vierling JM, Gordon SC, Anderson JK, Hyland RH, Dvory-Sobol H, An D, Hindes RG, Albanis E, Symonds WT, Berrey MM, Nelson DR, Jacobson IM. 2013. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet 381:2100-2107. http://dx.doi.org/10.1016/S0140-6736(13)60247-0.
4. Lawitz E, Poordad FF, Pang PS, Hyland RH, Ding X, Mo H, Symonds WT, McHutchison JG, Membreno FE. 2014. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. Lancet 383:515-523. http://dx.doi.org/10.1016/S0140-6736(13)62121-2.
5. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and assignment web resource. Hepatology 59:318-327. http://dx.doi.org/10.1002/hep.26744.
6. Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, Illeperuma A, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Weiland O, Reesink HW, Ferenci P, Hezode C, Esteban R. 2014. Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 370:1993-2001. http://dx.doi.org/10.1056/NEJMoa1316145.
7. European Association for Study of Liver. 2015. EASL recommendations on treatment of hepatitis C 2015. J Hepatol 63:199-236. http://dx.doi.org/10.1016/j.jhep.2015.03.025.
8. Donaldson EF, Harrington PR, O'Rear JJ, Naeger LK. 2015. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatology 61:56-65. http://dx.doi.org/10.1002/hep.27375.
9. Yoshimi S, Imamura M, Murakami E, Hiraga N, Tsuge M, Kawakami Y, Aikata H, Abe H, Hayes CN, Sasaki T, Ochi H, Chayama K. 2015. Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy. J Med Virol 87:1913-1920. http://dx.doi.org/10.1002/jmv.24255.
10. Bonsall D, Ansari M, Ip C, Trebes A, Brown A, Klenerman P. 2015. ve-SEQ: robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens. F1000Res 4:1062. http://dx.doi.org/10.12688/f1000research.7111.1.
11. Brant LJ, Ramsay ME, Tweed E, Hale A, Hurrelle M, Klapper P, Ngui SL. 2010. Planning for the healthcare burden of hepatitis C infection: hepatitis C genotypes identified in England, 2002-2007. J Clin Virol 48:115-119. http://dx.doi.org/10.1016/j.jcv.2010.03.018.
12. Major ME, Feinstone SM. 1997. The molecular virology of hepatitis C. Hepatology 25:1527-1538. http://dx.doi.org/10.1002/hep.510250637.
13. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225-3229.
14. Smith JA, Aberle JH, Fleming VM, Ferenci P, Thomson EC, Karayiannis P, McLean AR, Holzmann H, Klenerman P. 2010. Dynamic coinfection with multiple viral subtypes in acute hepatitis C. J Infect Dis 202:1770-1779. http://dx.doi.org/10.1086/657317.
15. Lambers FA, Prins M, Thomas X, Molenkamp R, Kwa D, Brinkman K, van der Meer JT, Schinkel J. 2011. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 25:F21-F27. http://dx.doi.org/10.1097/QAD.0b013e32834bac44.
16. McNaughton AL, Thomson EC, Templeton K, Gunson RN, Leitch EC. 2014. Mixed genotype hepatitis C infections and implications for treatment. Hepatology 59:1209. http://dx.doi.org/10.1002/hep.26544.
17. Brown JR, Roy S, Ruis C, Romero EY, Shah D, Williams R, Breuer J. 2016. Norovirus whole-genome sequencing by SureSelect target enrichment: a robust and sensitive method. J Clin Microbiol 54:2530-2537. http://dx.doi.org/10.1128/JCM.01052-16.